RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab (Q34331751)

1 August 2017

title

RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab (English)

1 reference

1 August 2017

1 reference

1 reference

adenoid cystic carcinoma

1 reference

inferred from title

heavy ion radiotherapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21047402

19 August 2024

3

Wilko Weichert

0 references

Jürgen Debus

series ordinal

4

object named as

Jürgen Debus

1 reference

1 August 2017

Jürgen Krauss

2

1 reference

1 August 2017

Alexandra D. Jensen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21047402

19 August 2024

Marc W. Münter

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21047402

19 August 2024

language of work or name

1 reference

3 November 2010

1 reference

full work available at URL

1 August 2017

https://ro-journal.biomedcentral.com/counter/pdf/10.1186/1748-717X-5-102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21047402

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21047402/?tool=EBI

19 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21047402

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21047402/pdf/?tool=EBI

19 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21047402

http://www.ro-journal.com/content/5//102/abstract

19 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21047402

http://www.ro-journal.com/content/pdf/1748-717X-5-102.pdf

19 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21047402

https://europepmc.org/articles/PMC2987937

19 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21047402

https://europepmc.org/articles/PMC2987937?pdf=render

19 August 2024

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21047402

http://link.springer.com/content/pdf/10.1186/1748-717X-5-102.pdf

19 August 2024

1 reference

Crossref

DOI

10.1186/1748-717X-5-102

https://api.crossref.org/works/10.1186/1748-717X-5-102

http://link.springer.com/article/10.1186/1748-717X-5-102/fulltext.html

19 August 2024

1 reference

10.1186/1748-717X-5-102

https://api.crossref.org/works/10.1186/1748-717X-5-102

19 August 2024

1 reference

1 August 2017

volume

5

1 reference

1 August 2017

page(s)

102

1 reference

Creative Commons Attribution 2.0 Generic

1 August 2017

copyright license

start time

3 November 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

The role of radiotherapy in the treatment of malignant salivary gland tumors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Chemoreirradiation for recurrent salivary gland malignancies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987937

Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy

27 October 2018

1 reference

12 December 2020

Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam?

1 reference

12 December 2020

Concomitant chemoradiotherapy followed by adjuvant chemotherapy in parotid gland undifferentiated carcinoma

1 reference

12 December 2020

Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin

1 reference

12 December 2020

Treatment of salivary gland neoplasms with fast neutron radiotherapy

1 reference

12 December 2020

Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck

1 reference

12 December 2020

Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer

1 reference

12 December 2020

Salivary neoplasms: overview of a 35-year experience with 2,807 patients

1 reference

12 December 2020

Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin

1 reference

12 December 2020

Cisplatin-based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck

1 reference

12 December 2020

Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck

1 reference

12 December 2020

Proton beam radiation therapy for skull base adenoid cystic carcinoma

1 reference

12 December 2020

Outcomes and Prognostic Variables in Adenoid Cystic Carcinoma of the Head and Neck: A Recent Experience

1 reference

12 December 2020

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

1 reference

12 December 2020

Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation

1 reference

12 December 2020

Identifiers

DOI

10.1186/1748-717X-5-102

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference